From: Circulating miRNAs in cancer: from detection to therapy
Circulating miRNA | Types of cancer | Methods | Source | References |
---|---|---|---|---|
miR-155,-210,-21 | Diffuse large B-cell lymphoma | qRT-PCR | serum | [14] |
miR-132, -181c, -15a, -370, -143-3p, -21-5p, -200a-3p, -646 | Cervical squamous cell carcinoma | TaqMan miRNA array, qRT-PCR | serum | [26] |
miR-122 | Chronic hepatitis B | Microarray, qRT-PCR | serum | [28] |
miR-141 | Prostate cancer | qRT-PCR | serum/plasma | |
miR-1233 | Renal cell carcinoma | TaqMan low density array, qRT-PCR | serum | [30] |
mir-16,-25 | Multiple myeloma | NanoString-nCounter microRNA assays | serum | |
miR-17, -20a, -29c, -223 | Nasopharyngeal carcinoma | Microarray, qRT-PCR | serum | [32] |
miR-17-3p, -29a, -92a, -221 | Colorectal Cancer | qRT-PCR | serum | |
miR-155 | Breast Cancer | TaqMan miRNA array, qRT-PCR | serum | |
miR-21, -26a, -27a, -122, -192, -223, -801 | Hepatocellular cancer | Microarray, qRT-PCR | serum | [48] |
miR-16, -25, -92a, -451, miR-486-5p | Gastric non-cardia adenocarcinoma | TaqMan low density array, qRT-PCR | serum | [50] |
miR-425-5p, -93-5p | Head and neck cancer | qRT-PCR | Plasma | [53] |
miR-122 | Chronic hepatitis C | qRT-PCR | serum | [55] |